A carregar...
FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
Despite billions of dollars invested in clinical trials to develop novel therapeutics for Alzheimer's disease, no approved treatments have been developed in the past 15 years. In that span, new classes of drugs have been developed and tested, including monoclonal antibodies, γ-secretase modulat...
Na minha lista:
| Publicado no: | Alzheimers Dement (N Y) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6804505/ https://ncbi.nlm.nih.gov/pubmed/31650002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.11.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|